murin
model
studi
enter
induc
bovin
brv
murin
rotaviru
mrv
develop
cours
infect
determin
clinic
symptom
diarrhea
viru
isol
well
histopatholog
immunohistochem
electron
microscop
method
isol
abl
replic
produc
clinic
symptom
neonat
mice
rotavirusfre
neonat
oral
inocul
mrv
brv
observ
postinocul
hpi
period
follow
infect
pfu
viru
diarrhea
maxim
intestin
dysfunct
measur
xylos
absorpt
occur
beyond
hr
postinfect
even
though
maxim
viru
product
occur
hpi
immunohistochem
electron
microscopi
abl
demonstr
viral
antigen
viru
particl
enterocyt
villou
tip
hpi
appear
symptom
depend
viru
dose
type
viru
isol
inocul
diseas
could
induc
dose
low
x
pfuimous
brv
x
pfumous
mrv
basi
result
mrv
found
virul
brv
model
model
prove
use
studi
design
assess
rotaviru
virul
gene
vaccin
protect
studi
work
emphas
need
earli
sampl
collect
critic
evalu
vaccin
antivir
agent
use
model
academ
press
ii
sinc
discoveri
rotaviru
fece
calv
suffer
diarrhea
mebu
et
al
report
rotavirus
ubiquit
anim
human
pathogen
caus
signific
diseas
mammalian
avian
speci
review
babiuk
babiuk
et
al
flewett
babiuk
rotavirus
constitut
genu
famili
reovirida
infecti
viral
particl
character
doubleshel
capsid
surround
icosahedr
core
contain
segment
doublestrand
rna
associ
enter
young
anim
month
infant
month
year
flewett
babiuk
estim
x
case
diarrhea
occur
annual
human
result
either
directli
indirectli
approxim
x
death
approxim
x
attribut
rotavirus
review
babiuk
although
accur
estim
number
case
anim
avail
believ
least
high
human
thu
indic
econom
import
diseas
estim
approxim
calv
born
north
america
die
diarrhea
reach
month
age
basi
find
estim
loss
unit
state
averag
million
world
wide
basi
billion
annual
review
ratafia
signific
role
play
virus
acut
neonat
enter
creat
worldwid
impetu
develop
appropri
vaccin
jen
chanock
et
al
jordan
ratatia
vaccin
yet
avail
order
develop
effect
method
prevent
control
effort
direct
develop
anim
model
rotavirusinduc
diarrhea
would
mimic
human
month
year
conner
et
al
anim
month
eiden
et
al
eydelloth
et
al
gouvea
et
al
otfit
et
al
offor
et
al
ramig
riepenhofftalti
et
al
starkey
et
al
wolf
et
al
situat
order
test
rotaviru
vaccin
develop
laboratori
develop
murin
model
murin
rotaviru
mrv
bovin
rotaviru
brv
infect
rotavirusinduc
diarrhea
produc
first
week
neonat
life
thu
mimick
time
diseas
preval
natur
case
studi
conduct
determin
effect
viru
dose
induct
clinic
diseas
diarrhea
kinet
viru
replic
murin
intestin
tract
model
prove
use
studi
aim
identifi
rotaviru
gene
et
al
involv
pathogenesi
diseas
express
immunogen
viru
rotavirusfre
mice
obtain
charl
river
breed
laboratori
wilmington
order
ensur
previous
expos
rotaviru
bled
coccyg
vein
arriv
sera
test
rotaviru
antibodi
use
enzymelink
immunosorb
assay
describ
previous
ijaz
et
al
mice
found
seroneg
maintain
rotaviru
free
anim
hous
isol
unit
throughout
experi
allow
give
birth
natur
bovin
rotaviru
isol
cultur
fece
diarrheic
calv
method
describ
previous
babiuk
et
al
mous
rotaviru
kindli
provid
dr
cepica
atlant
veterinari
colleg
univers
pei
canada
viru
isol
propag
confluent
african
green
monkey
kidney
cell
pg
trypsin
difco
laboratori
detroit
mi
per
millilit
absenc
fetal
bovin
serum
fb
gibco
laboratori
grand
island
ny
cell
normal
cultur
eagl
minim
essenti
media
mem
supplement
fb
brv
mrv
grown
cell
harvest
clarifi
centrifug
min
virus
concentr
clarifi
supernat
fluid
pellet
sucros
cushion
tpm
rotor
beckman
hr
viru
pellet
resuspend
doubl
distil
water
amount
viru
protein
estim
spectrophotometr
describ
previous
ijaz
et
al
plaqu
assay
quantit
brv
mrv
perform
accord
method
describ
previous
ijaz
et
al
smith
et
al
cell
monolay
plate
wash
three
time
mem
remov
much
fb
possibl
cultur
everi
well
inocul
ml
appropri
dilut
viru
suspens
infect
allow
take
place
hr
co
incub
end
incub
period
inoculum
remov
monolay
overlaid
ml
medium
contain
mem
nobel
agar
ml
pancreatin
mm
glutamin
pgml
deae
dextran
plate
incub
day
time
monolay
fix
formalinsalin
stain
crystal
violet
plaqu
enumer
vitro
replic
kinet
brv
mrv
cell
infect
either
brv
mrv
multipl
infect
moi
pfucel
describ
earlier
carpio
et
al
follow
infect
monolay
wash
remov
unadsorb
viru
variou
time
postinfect
entir
cultur
harvest
scrape
cell
rubber
policeman
sonic
releas
intracellular
viru
viru
quantit
plaqu
cell
describ
design
sampl
procedur
neonat
day
old
use
experi
order
determin
viru
dose
kinet
viru
replic
group
neonat
logroupdilut
inocul
decreas
concentr
rotaviru
isol
io
io
pfumous
prepar
administ
intub
stomach
soft
flexibl
plastic
feed
tube
trypan
blue
dye
gibco
use
marker
assess
accuraci
inocul
viru
infect
evalu
clinic
hr
postinocul
hpi
order
determin
kinet
brv
mrv
replic
neonat
mice
mice
group
sacrif
differ
time
interv
postinocul
hr
intestin
dissect
store
quantit
viru
intestin
suspend
mem
weightvolum
homogen
use
tissu
homogen
brinkman
instrument
ontario
canada
centrifug
eppendorf
centrifug
supernat
aliquot
use
viru
quantit
plaqu
assay
xylos
absorpt
test
perform
measur
small
intestin
dysfunct
follow
infect
describ
previous
ijaz
et
al
briefli
anim
inocul
brv
mrv
placebo
distil
water
differ
time
postinfect
given
dxylos
wv
solut
dxylos
two
hour
administr
xylos
sacrif
decapit
blood
collect
heparin
hematocrit
tube
plasma
collect
assay
dxylos
concentr
describ
previous
ijaz
et
al
electropherotyp
rotaviru
rna
electropherotyp
brv
mrv
rna
perform
describ
earlier
sabara
et
al
briefli
viru
isol
intestin
sampl
cultur
cell
partial
purifi
sucros
describ
earlier
rna
extract
phenolchloroform
mixtur
electrophores
laemmli
discontinu
system
polyacrylamid
gel
hr
band
doublestrand
rna
visual
ethidium
bromid
stain
stain
rotavirusinfect
intestin
epitheli
enterocyt
intestin
epitheli
enterocyt
isol
procedur
describ
previous
riepenhofftalti
et
al
weiser
briefli
differ
time
postinocul
viru
small
intestin
remov
minc
wash
phosphatebuff
salin
pb
place
pb
contain
f
edta
agit
gentli
min
procedur
result
popul
cell
compris
approxim
epitheli
enterocyt
releas
media
cell
wash
thoroughli
cytospin
prepar
made
clean
glass
slide
use
cytocentrifug
shandon
southern
instrument
inc
sweickley
pa
cell
fix
min
cold
aceton
incub
monoclon
antibodi
direct
viru
brv
stain
fluoresceinlabel
goat
antimous
igg
boehringermannheim
biochem
mannheim
west
germani
histopatholog
examin
infect
tissu
sampl
upper
middl
lower
small
intestin
fix
buffer
formaldehyd
immunofluoresc
fresh
segment
intestin
frozen
cryostat
mount
media
liquid
nitrogen
kept
sixmicromet
frozen
section
cut
cryostat
mount
polyllysin
hydrobromid
mw
sigma
chemic
co
st
loui
mo
solut
coat
glass
slide
section
allow
air
dri
fix
min
cold
aceton
wash
min
pb
ph
nonspecif
adher
antirotaviru
antibodi
section
block
pretreat
slide
normal
goat
serum
pb
slide
incub
humid
chamber
minut
excess
normal
serum
remov
dilut
rabbit
antibodi
rotaviru
normal
goat
serum
pb
appli
onto
section
slide
incub
min
humid
chamber
follow
three
wash
min
pb
dilut
fluoresceinlabel
antirabbit
igg
cappel
malnein
pa
appli
section
slide
incub
humid
chamber
min
wash
repeat
slide
final
mount
buffer
glycerol
examin
fluoresc
microscopi
excit
nm
transmiss
electron
microscopi
sampl
upper
middl
lower
small
intestin
fix
hr
glutaraldehyd
pb
ph
within
set
decapit
glutaraldehydefix
specimen
postfix
embed
spurr
resin
ultrathin
section
stain
methanol
uranyl
acet
wv
follow
lead
citrat
examin
aid
philip
model
ls
electron
microscop
kv
coelho
et
al
determin
differ
vitro
kinet
replic
two
isol
cell
infect
either
viru
pfucel
follow
infect
high
viru
fig
increas
infecti
viru
could
detect
peak
mrv
brv
respect
howev
cell
infect
lower
appear
increas
level
infecti
viru
delay
mrv
brv
respect
viru
peak
mrv
brv
respect
order
abl
test
protect
rotaviru
challeng
neonat
anim
mous
model
develop
initi
studi
perform
investig
minim
amount
viru
requir
induc
diarrhea
neonat
mice
kinet
replic
brv
mrv
murin
enterocyt
vivo
condit
neonat
age
day
inocul
either
brv
mrv
separ
group
ten
mice
group
sacrif
differ
time
interv
postinocul
hr
result
repres
experi
shown
fig
sampl
taken
within
hr
postinocul
result
titer
virtual
equival
inoculum
data
shown
viru
titer
drop
fig
suggest
viru
either
inactiv
intestin
content
taken
enterocyt
convert
noninfecti
form
interest
observ
diarrhea
began
quantiti
viru
intestin
content
drop
dramat
detect
diarrheic
phase
fig
tabl
legend
clinic
score
higher
viru
dose
approxim
pfu
use
intestin
viru
reach
input
titer
peak
appar
viru
replic
suggest
either
replic
limit
high
input
viru
result
rapid
death
slough
cell
produc
maxim
level
infecti
viru
data
shown
correl
found
rapid
intestin
function
decreas
dose
challeng
viru
fig
clinic
appear
symptom
depend
viru
dose
type
viru
isol
inocul
tabl
case
brvinocul
anim
infect
pfu
onset
diarrhea
first
occur
hpi
symptom
maxim
persist
addit
hr
subsid
onset
symptom
delay
neonat
mice
inocul
lower
viru
dose
recoveri
earlier
higher
viru
doseinocul
group
instanc
mice
inocul
mrv
sever
diarrhea
inocul
brv
clinic
symptom
observ
pfu
brv
inocul
evid
mrvinfect
mice
necropsi
colon
content
control
anim
found
semisolid
consist
contrast
diarrheic
mice
colon
content
liquid
mucoid
bright
lemon
yellow
amber
graygreen
diarrheic
mice
colon
two
hour
dxylos
administr
sacrif
blood
collect
heparin
hematocrit
tube
plasma
collect
centrifug
bloodfil
hematocrit
tube
assay
dxylos
concentr
describ
text
cecum
distend
ga
infect
anim
also
exhibit
extern
soil
around
anal
region
order
monitor
rate
intestin
damag
caus
brv
mrv
follow
infect
neonat
mice
oxylos
absorpt
test
perform
result
experi
shown
fig
case
rotavirusinocul
mice
plasma
dxylos
concentr
lower
control
mice
also
group
inocul
mrv
reveal
decreas
xylos
absorpt
maintain
rapid
anim
inocul
brv
reflect
sever
damag
caus
mrv
fig
none
mockinfect
anim
show
clinic
symptom
diarrhea
presenc
malabsorpt
determin
xylos
absorpt
test
presenc
infecti
rotaviru
detect
plaqu
assay
histopatholog
techniqu
immunohistochem
examin
virusznfect
intestin
tissu
zsolat
enterocyt
histopatholog
lesion
consist
enlarg
vacuol
cell
de
x
x
x
extern
sign
semiliquid
colon
content
diarrhea
present
palpat
abdomen
colon
fill
liquid
fece
ga
extern
anal
region
soil
fece
diarrhea
present
palpat
extern
examin
dri
fece
around
anal
region
closur
anal
caviti
palpat
diarrhea
present
fluid
ooz
sever
dehydr
intern
liquid
content
colon
cecum
distent
due
accumul
ga
struction
villu
tip
observ
sampl
taken
earli
mrv
brv
fig
higher
multipl
infect
use
viru
antigen
could
also
demonstr
cytoplasm
isol
enterocyt
fluoresc
regularli
detect
materi
collect
earli
infect
disappear
antigen
correl
slough
infect
cell
repres
pattern
immunofluoresc
stain
isol
virusinfect
enterocyt
present
fig
electron
microscopi
small
intestin
oral
infect
mice
pfu
reveal
extens
vacuol
cytoplasm
infect
cell
fig
presenc
singl
doubl
shell
particl
fig
viru
particl
seen
microvilli
well
within
cytoplasm
fig
intestin
homogen
due
rapid
diarrhea
occur
follow
infect
import
confirm
mice
suffer
diarrhea
result
accident
infect
extran
sourc
achiev
analyz
rna
recov
viru
page
rotaviru
isol
recov
intestin
suspens
identifi
brv
mrv
characterist
electrophoret
pattern
rna
genom
fig
studi
demonstr
homolog
mrv
heterolog
brv
rotaviru
isol
infect
replic
murin
model
antirotaviru
antibodyfre
mice
infecti
viru
product
peak
within
lead
clinic
yellowish
diarrhea
hour
later
mrv
much
virul
human
anim
rotavirus
use
model
clinic
symptom
observ
use
brv
mrv
present
studi
found
accord
edim
report
elsewher
kraft
differ
occur
much
earlier
studi
report
edim
rotaviru
isol
use
mous
model
kraft
offit
et
al
observ
maximum
viru
product
intestin
occur
onset
diarrhea
suggest
virusinfect
cell
slough
rapidli
remov
intestin
result
diarrhea
intestin
dysfunct
agreement
propos
pathogenesi
rotavirusinduc
diseas
diarrhea
continu
intestin
enterocyt
regener
observ
higher
dose
input
viru
induc
diarrhea
quicker
indic
cell
kill
rapidli
regener
take
longer
suggest
fulli
support
input
multipl
infect
kinet
viru
replic
induct
diseas
tabl
fig
sevendayold
neonat
mice
select
studi
kinet
viru
replic
follow
reason
first
demonstr
reipenhofftalti
et
al
maximum
receptor
rotavirus
present
day
age
second
mice
easier
handl
ldayold
mice
third
one
goal
investig
potenti
lactogen
immun
protect
mice
diarrhea
result
previou
experi
ijaz
et
al
reveal
highest
titer
antirotaviru
neutral
antibodi
present
day
report
eydelloth
et
al
gouvea
et
al
kraft
offrt
et
al
ramig
starkey
et
al
wolf
et
al
howev
peak
infecti
viru
occur
earlier
studi
suggest
rate
replic
isol
much
faster
human
anim
ro
taviru
isol
use
mous
model
among
two
isol
use
mrv
en
found
virul
brv
model
evid
clinic
use
dxylos
absorpt
test
differ
consist
earlier
vitro
vivo
studi
compar
two
isol
sabara
er
al
result
present
studi
infect
replic
homolog
heterolog
rotaviru
murin
model
confirm
extend
report
other
eydelloth
et
al
gouvea
et
al
kraft
offrt
et
al
ramig
starkey
et
al
wolf
et
al
howev
result
differ
previou
report
sever
respect
use
approxim
pfumous
heterolog
well
homolog
rotaviru
demonstr
replic
diseas
symptom
lower
dose
viru
would
produc
diseas
mice
studi
demonstr
replic
also
product
clinic
symptom
dose
low
pfumous
tabl
clinic
diarrhea
observ
much
earlier
studi
eydelloth
et
al
gouvea
et
al
kraft
offtt
et
al
ramig
starkey
et
al
wolfet
al
high
dose
use
symptom
observ
earli
continu
hpi
studi
took
hr
follow
infect
induc
clinic
symptom
length
clinic
symptom
time
requir
recov
infect
longer
report
investig
biphas
natur
infecti
rotaviru
rotaviru
antigen
product
report
studi
use
mice
seen
present
studi
drop
infecti
rotaviru
titer
could
seen
result
acceler
viru
clearanc
associ
start
symptom
loss
enterocyt
bear
rotaviru
specif
receptor
requir
infect
continu
infecti
viru
recov
hr
postinfect
despit
presenc
diarrhea
symptom
differ
explain
high
virul
mice
specif
isol
use
studi
pathogenesi
rotaviru
infect
also
investig
anim
model
includ
gnotobiot
calv
mebu
ef
al
tzipori
et
al
lamb
snodgrass
et
al
tzipori
et
al
piglet
crouch
wood
gaul
et
al
hall
et
al
leec
et
al
theil
et
al
tzipori
et
al
viru
tropism
anim
like
murin
model
describ
limit
enterocyt
line
upper
region
intestin
villi
howev
patholog
extrem
sever
piglet
complet
eros
jejun
villi
report
theil
et
al
denud
upper
region
affect
villi
observ
speci
leav
lamina
properia
expos
type
patholog
observ
studi
either
brv
mrv
infect
similarli
infect
anim
human
rotavirus
murin
model
report
caus
sever
patholog
lesion
coelho
et
al
earlier
experi
virul
two
rotaviru
isol
also
compar
calf
model
use
ligat
intestin
loop
techniqu
sabara
et
al
result
reveal
cattl
mrv
also
virul
sinc
induc
fluid
intestin
loop
brv
sabara
et
al
differ
virul
brv
mrv
confirm
vitro
condit
sabara
et
al
comparison
kinet
protein
synthesi
reveal
brv
protein
identifi
hpi
wherea
case
mrv
sever
virusspecif
protein
present
time
result
correl
vitro
observ
cytopathogen
effect
cpe
cell
infect
mrv
cpe
occur
almost
immedi
viru
adsorpt
cell
wherea
brv
cpe
observ
hr
adsorpt
unpublish
data
demonstr
brv
mrv
use
studi
differ
far
concern
analysi
brv
mrv
carboxypeptidas
digest
reveal
one
region
heterogen
two
virus
area
span
amino
acid
differ
brv
mrv
manifest
basi
sensit
chelat
agent
sabara
et
al
observ
differ
virul
two
virus
vivo
condit
may
consequ
observ
differ
outer
shell
protein
mrv
compar
brv
specif
differ
primari
structur
amino
acid
may
one
factor
contribut
increas
virul
mrv
result
abovement
vitro
studi
taken
togeth
vivo
data
tend
support
replic
kinet
brv
mrv
model
use
present
studi
develop
model
rotaviru
provid
tool
use
studi
pathogenesi
viru
well
facilit
vivo
evalu
differ
antivir
agent
vaccin
produc
virus
